Adaptimmune To Present Data From Primary Analysis Of Phase 2 IGNYTE-ESO Trial; Says Results Include Six Complete Responses And Twenty One Partial Responses
Adaptimmune To Present Data From Primary Analysis Of Phase 2 IGNYTE-ESO Trial; Says Results Include Six Complete Responses And Twenty One Partial Responses
Adaptimmune將就2期IGNYTE-ESO試驗的初步分析數據進行展示；結果顯示有六個完全反應和二十一個部分反應
Adaptimmune To Present Data From Primary Analysis Of Phase 2 IGNYTE-ESO Trial; Says Results Include Six Complete Responses And Twenty One Partial Responses
Adaptimmune將就2期IGNYTE-ESO試驗的初步分析數據進行展示；結果顯示有六個完全反應和二十一個部分反應
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間